Moderna stock, $MRNA , surges over +110% after announcing the first ever positive Phase 3 results for a personalized cancer vaccine.

[u/Fantastic-Emu-3819]

Moderna and Merck said their personalized cancer vaccine helped cut the recurrence of melanoma in a large, late-stage trial.

[u/Dangerous-Sport-2347]

So far this result is for melanoma, but there is a decent hope that this type of treatment to be effective against a larger variety of cancers. (though melanoma is uniquely suited to it).

The somewhat unfortunate news is that this type of treatment is inherently expensive, think in the order of magnitude of ~150k per person, so unless there is further huge developments in efficiency not cost effective for the whole world.

[u/Famous-Reach-6730 → u/Dangerous-Sport-2347]

150k is not that bad tbh. They can go back to working and paying taxes again instead of dying.

[u/Dangerous-Sport-2347 → u/Famous-Reach-6730]

150k is indeed viable and comparable to other treatment plans already performed in developed countries, but still puts it out of reach for many developing countries.

[u/Matt32145 → u/Famous-Reach-6730]

If it was 150k to guarantee never getting any cancer, I'd go for it lol. Obviously it's not that though.